- Circulating tumor DNA in patients with metastatic prostate cancer treated with abiraterone acetateLoriot, Y.*; Fizazi, K.Annals of Oncology, 2021, 32(6): 694-695.
- Abiraterone acetate: A novel drug for castration-resistant prostate carcinomaR, NandhaJournal of Postgraduate Medicine, 2012, 58(3): 203.
- Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsyZhou Chenchao; Zhang Jun; Chen Ye; Wang Hao; Hou JianquanOncoTargets and Therapy, 2017, 10: 3485-3491.
期刊论文
Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer
2被引11阅读
